FIA
GILD icon

FNY Investment Advisers’s Gilead Sciences GILD Stock Holding History

FNY Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73
Closed -$8K – 903
2025
Q4 		$8K Buy
+73
New +$8.87K ﹤0.01% 684
2021
Q1 		– Sell
-280
Closed -$16K – 872
2020
Q4 		$16K Buy
+280
New +$16.9K ﹤0.01% 549

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

FNY Investment Advisers's GILD Position: Q1 2026 in Review

FNY Investment Advisers sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 4,700 shares — an estimated $576K sold.

FNY Investment Advisers first reported a position in GILD in Q3 2018 and held it in 8 quarters. The position peaked at $576K in Q4 2025. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • FNY Investment Advisers reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 4,700 Gilead Sciences shares in Q1 2026, an estimated $576K.
  • FNY Investment Advisers first reported a position in Gilead Sciences in Q3 2018 and held it in 8 quarters.
  • FNY Investment Advisers's Gilead Sciences position peaked at $576K in Q4 2025.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.